Noble Financial restated their buy rating on shares of NCI, Inc. (NASDAQ:NCIT) in a research report sent to investors on Wednesday.

A number of other brokerages have also weighed in on NCIT. Zacks Investment Research raised NCI from a sell rating to a hold rating in a research report on Saturday, May 13th. Cowen and Company reaffirmed a buy rating and set a $16.50 target price on shares of NCI in a research report on Monday, April 10th. FBR & Co reaffirmed a hold rating and set a $11.00 target price on shares of NCI in a research report on Tuesday, April 4th. Finally, ValuEngine raised NCI from a hold rating to a buy rating in a research report on Friday, June 2nd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. NCI has an average rating of Buy and a consensus target price of $17.50.

NCI (NASDAQ NCIT) traded down 0.24% during mid-day trading on Wednesday, reaching $20.55. The company had a trading volume of 7,115 shares. The firm’s 50-day moving average is $17.74 and its 200-day moving average is $14.84. NCI has a one year low of $10.98 and a one year high of $20.89. The firm has a market capitalization of $278.47 million, a P/E ratio of 45.97 and a beta of 0.98.

NCI (NASDAQ:NCIT) last issued its quarterly earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.21 by $0.04. NCI had a return on equity of 11.73% and a net margin of 2.13%. The firm had revenue of $78.75 million for the quarter, compared to analyst estimates of $76.55 million. On average, equities research analysts anticipate that NCI will post $1.01 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “NCI’s (NCIT) Buy Rating Reaffirmed at Noble Financial” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/06/15/ncis-ncit-buy-rating-reaffirmed-at-noble-financial.html.

Institutional investors have recently modified their holdings of the company. Royce & Associates LP purchased a new position in shares of NCI during the first quarter worth $7,663,000. Renaissance Technologies LLC raised its position in shares of NCI by 5.2% in the first quarter. Renaissance Technologies LLC now owns 404,799 shares of the information technology services provider’s stock worth $6,092,000 after buying an additional 20,074 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of NCI by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 303,739 shares of the information technology services provider’s stock worth $4,571,000 after buying an additional 3,044 shares during the last quarter. Vanguard Group Inc. raised its position in shares of NCI by 3.5% in the first quarter. Vanguard Group Inc. now owns 301,397 shares of the information technology services provider’s stock worth $4,536,000 after buying an additional 10,151 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of NCI by 6.7% in the first quarter. Geode Capital Management LLC now owns 90,650 shares of the information technology services provider’s stock worth $1,364,000 after buying an additional 5,688 shares during the last quarter. 39.04% of the stock is currently owned by institutional investors.

About NCI

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.